Melanoma
Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.
UK Consortium Launches With Public-Private Funding to ID Immunotherapy Biomarkers
The Francis Crick Institute and the Royal Marsden Foundation Trust are spearheading the MANIFEST project with £21.9 million in government and industry funding.
DermTech Sells Assets, Becomes Private Company
Derm-Jes had acquired substantially all DermTech assets through a court-approved auction following DermTech's bankruptcy filing in June.
DermTech Files for Bankruptcy, Lays off 20 Percent of Workforce
The firm intends to continue its laboratory operations and processing orders for its melanoma test while selling almost all of its assets.
Castle Biosciences Builds Skin Cancer Assay Data, Eyes Future Expansion as Q1 Sales Jump 74 Percent
Premium
The company highlighted clinical research progress for its two skin cancer tests and said it hopes to expand in the gastrointestinal cancer space in coming years.